Trial NCT02551055

View at ClinicalTrials.gov 
Org. Study IDs: C032-6001 (MLN1117-1003)
Secondary IDs: 2015-001032-38 REec-2016-2039 U1111-1166-8653

Last trial update was posted on 2019-09-20

MeSH Interventions

Docetaxel Paclitaxel Serabelisib

MeSH Conditions

Adenocarcinoma

Other Conditions

Advanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma

Stopping Reasons

Business Decision; No Safety Or Efficacy Concerns.

Limitations And Caveats

Due to the early termination of the study, the pharmacokinetic data collected was not processed further. Therefore, the planned secondary endpoints of PK summary statistics are not reported.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID